药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rolitetracycline
Ezogabine
The risk or severity of QTc prolongation can be increased when Ezogabine is combined with Dabrafenib.
Rolitetracycline
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Dabrafenib.
Rolitetracycline
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Dabrafenib.
Rolitetracycline
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Dabrafenib.
Rolitetracycline
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Dabrafenib.
Rolitetracycline
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Dabrafenib.
Rolitetracycline
Methotrimeprazine
The risk or severity of QTc prolongation can be increased when Methotrimeprazine is combined with Dabrafenib.
Rolitetracycline
Fostemsavir
Dabrafenib may decrease the excretion rate of Fostemsavir which could result in a higher serum level.
Rolitetracycline
Lusutrombopag
Dabrafenib may decrease the excretion rate of Lusutrombopag which could result in a higher serum level.
Rolitetracycline
Paritaprevir
Paritaprevir may decrease the excretion rate of Dabrafenib which could result in a higher serum level.
Rolitetracycline
Delafloxacin
Dabrafenib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Rolitetracycline
Ertugliflozin
Dabrafenib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
Rolitetracycline
Talazoparib
Dabrafenib may decrease the excretion rate of Talazoparib which could result in a higher serum level.
Rolitetracycline
Fimasartan
Dabrafenib may decrease the excretion rate of Fimasartan which could result in a higher serum level.
Rolitetracycline
Sofosbuvir
Dabrafenib may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Rolitetracycline
Dolutegravir
Dabrafenib may decrease the excretion rate of Dolutegravir which could result in a higher serum level.
Rolitetracycline
Isavuconazole
The serum concentration of Dabrafenib can be increased when it is combined with Isavuconazole.
Rolitetracycline
Pitolisant
The serum concentration of Dabrafenib can be decreased when it is combined with Pitolisant.
Rolitetracycline
Delamanid
Dabrafenib may increase the QTc-prolonging activities of Delamanid.
Rolitetracycline
Apalutamide
The serum concentration of Apalutamide can be increased when it is combined with Dabrafenib.